Polyrizon Ltd stock is traded at $11.59, with a volume of 24,577. It is up +4.18% in the last 24 hours and up +19.86% over the past month. Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Previous Close:
$11.13
Open:
$10.98
24h Volume:
24,577
Relative Volume:
1.14
Market Cap:
$28.15M
Revenue:
-
Net Income/Loss:
-$3.34M
P/E Ratio:
-
EPS:
-$2.70
Net Cash Flow:
-$10.54M
1W Performance:
+7.81%
1M Performance:
+19.86%
6M Performance:
-19.15%
1Y Performance:
+110.86%
1-Day Range:
$0.00$0.00
1-Week Range:
$10.67$12.34
52-Week Range:
$2.88$18.20
Polyrizon Ltd Stock (PLRZ) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS